Back

Seres Therapeutics Quote, Financials, Valuation and Earnings

New Year, New Trades, Try A.I. Today

Learn to forecast trends with up to 87.4% proven accuracy -> Register Here

Sell

MCRB
Seres Therapeutics

Last Price:

5.65

Seasonality Move:

-6.67%

7 Day Trial

ALL ACCESS PASS

$ 7

Your Chance To Invest In The Green Energy Revolution!

Don't miss this one - click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!

Seres Therapeutics Price Quote

$5.65

+0.16 (+2.91%)

(Updated: February 2, 2023 at 7:50 PM ET)

Seres Therapeutics Key Stats

Sell

Seres Therapeutics (MCRB) is a Sell

Day range:

$5.36 - $5.57

52-week range:

$2.50 - $9.49

Dividend yield:

P/E ratio:

0.00

P/S ratio:

3.73

P/B ratio:

29.69%

Volume:

896.8K

Avg. volume:

693.7K

1-year change:

-33.86%

Market cap:

$684.6M

Revenue:

$144.9M

EPS:

$-1.14

How Much Does Seres Therapeutics Make?

How Much Are Seres Therapeutics's Sales Annually?
MCRB Revenues are $144.9M
How Much Profit Does Seres Therapeutics's Make A Year?
MCRB net income is -$65.6M

Is Seres Therapeutics Growing As A Company?

What Is Seres Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.77%
What Is Seres Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Seres Therapeutics Stock Price Performance

Did Seres Therapeutics Stock Go Up Last Month?
Seres Therapeutics share price went down by -1.96% last month
Did MCRB's Share Price Rise Over The Last Year?
MCRB share price fell by -33.86% over the past 1 year

What Is Seres Therapeutics 52-Week High & Low?

What Is Seres Therapeutics’s 52-Week High Share Price?
Seres Therapeutics has traded as high as $9.49 over the past 52 weeks
What Is Seres Therapeutics’s 52-Week Low Share Price?
Seres Therapeutics has traded as low as $2.50 over the past 52 weeks

Seres Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Seres Therapeutics?

How Much Debt Does Seres Therapeutics Have?
Total long term debt quarterly is $50.6M
How Much Cash Does Seres Therapeutics Have?
Cash and short term investments quarterly total is $195.8M
What Is Seres Therapeutics’s Book Value Per Share?
Book value per share is 0.25

Is Seres Therapeutics Cash Flow Positive?

What Is MCRB Cash Flow From Operations?
Cash flow from operations (TTM) is -$40.5M
What Is Seres Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $26.8M
What Is Seres Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $74.7M

Seres Therapeutics Return On Invested Capital

Is Management Doing A Good Job?
MCRB return on invested capital is -74.87%
What Is Seres Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -31.96%
What Is MCRB Return On Equity?
ROE is a measure of profitability and is -100.66%

Seres Therapeutics Earnings Date & Stock Price

What Is Seres Therapeutics's Stock Price Today?
A single share of MCRB can be purchased today for 5.49
What Is Seres Therapeutics’s Stock Symbol?
Seres Therapeutics trades on the nasdaq under the ticker symbol: MCRB
When Is Seres Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Seres Therapeutics is scheduled on March 1, 2023
When Is MCRB's next ex-dividend date?
Seres Therapeutics's next ex-dividend date is February 3, 2023
How To Buy Seres Therapeutics Stock?
You can buy Seres Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Seres Therapeutics Competitors

Who Are Seres Therapeutics's Competitors?
Below is a list of companies who compete with Seres Therapeutics or are related in some way:
- Design Therapeutics Inc (DSGN)
- Inhibrx Inc (INBX)
- Protagonist Therapeutics Inc (PTGX)
- scPharmaceuticals Inc (SCPH)
- Stoke Therapeutics Inc (STOK)

Seres Therapeutics Dividend Yield